You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 16, October 25, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We would like to raise possible reasons for the treatment failure of granulocyte colony-stimulating factor (G-CSF) in the Regenerate Vital Myocardium by Vigorous Activation of Bone Marrow Stem Cells (REVIVAL-2) trial by Dr Zohlnhöfer and colleagues1 based on what we believe to be the mechanism of action of G-CSF in both the myocardium and the brain.

Protective effects of G-CSF in experimental acute myocardial infarction (AMI) or stroke have been shown,2-4 but the probable mechanism of action has remained uncertain. Most studies have assumed activation and mobilization of bone marrow–derived stem cells by G-CSF that integrate into the infarcted organ and contribute to recovery by transdifferentiation or other unknown mechanisms. Based on this assumption, REVIVAL-2 was designed with a delayed treatment start (5 days after AMI), and with a G-CSF dose sufficient to stimulate bone marrow mobilization (10 µg/kg per day for 5 days).1 However, recent evidence . . . [Full Text of this Article]

Wolf-Rüdiger Schäbitz, MD
schabitz@uni-muenster.de
Department of Neurology

Sigrid Nikol, MD
Department of Cardiology
University of Münster
Münster, Germany

Armin Schneider
Axaron Bioscience AG
Heidelberg, Germany



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction
Jaewon Oh, Dae Hyun Kim, and Hyunseok Kang
JAMA. 2006;296(16):1968.
EXTRACT | FULL TEXT  

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction—Reply
Dietlind Zohlnhöfer, Ilka Ott, Adnan Kastrati, and Albert Schömig
JAMA. 2006;296(16):1968-1969.
EXTRACT | FULL TEXT  

Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial
Dietlind Zohlnhöfer, Ilka Ott, Julinda Mehilli, Kathrin Schömig, Fabian Michalk, Tareq Ibrahim, Günther Meisetschläger, Jasper von Wedel, Hildegard Bollwein, Melchior Seyfarth, Josef Dirschinger, Claus Schmitt, Markus Schwaiger, Adnan Kastrati, Albert Schömig, and for the REVIVAL-2 Investigators
JAMA. 2006;295(9):1003-1010.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.